Delivery Order SPE2DB24D3013-SPE2DB25FFQRM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,373.51 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion, a prescription ophthalmic medication, with an ultimate completion date of August 13, 2025. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside basis. The award was made to AmerisourceBergen's Corporate Office division, with performance occurring at the company's Conshohocken, Pennsylvania headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.74 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion, a prescription ophthalmic medication used to treat dry eye disease. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.46 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60-unit supply) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award through open procurement channels. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,117.68 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,929.30 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (30 count) on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader federal pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,947.09 firm-fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion, a prescription eye medication. The order is placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $6,110.43 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive procurement under AmerisourceBergen's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,550.26 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,509.57 delivery order to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60 count) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RESTASIS is a prescription ophthalmic emulsion used to treat dry eye syndrome, a condition common among...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.69 to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count), a prescription ophthalmic medication commonly used to treat dry eye disease. This non-set-aside, competitively awarded contract utilized firm fixed pricing and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQRMDelivery Order
The Defense Logistics Agency awarded a $2,999.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion, a prescription ophthalmic medication used to treat dry eye disease. The contract, which carries an ultimate completion date of September 18, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor for federal military and veteran healthcare systems. The company leverages its comprehensive IDC with DLA to supply a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare programs. No set-aside designation applied to this award, consistent with AmerisourceBergen's pattern of competitive procurement through open contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/17/25 |